RENEO PHARMACEUTICALS INC's ticker is RPHM and the CUSIP is 75974E103. A total of 34 filers reported holding RENEO PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $274 | -31.7% | 36,000 | -41.1% | 0.00% | -100.0% |
Q2 2023 | $401 | +162.1% | 61,114 | +138.7% | 0.00% | – |
Q1 2023 | $153 | +75.9% | 25,600 | -31.2% | 0.00% | – |
Q4 2022 | $87 | -99.9% | 37,200 | -13.5% | 0.00% | – |
Q3 2022 | $144,000 | +136.1% | 43,000 | +87.0% | 0.00% | – |
Q2 2022 | $61,000 | – | 23,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RiverVest Venture Management LLC | 2,409,220 | $8,071,000 | 9.37% |
Abingworth LLP | 2,073,957 | $6,948,000 | 2.38% |
Aisling Capital Management LP | 886,075 | $2,968,000 | 1.97% |
NEA Management Company, LLC | 4,786,921 | $16,036,000 | 0.80% |
Novo Holdings A/S | 3,430,377 | $11,492,000 | 0.55% |
Ikarian Capital, LLC | 155,819 | $521,000 | 0.10% |
Rock Springs Capital Management LP | 1,143,185 | $3,830,000 | 0.10% |
Ergoteles LLC | 37,640 | $126,000 | 0.00% |
MAI Capital Management | 63,210 | $212,000 | 0.00% |
RBF Capital, LLC | 14,536 | $49,000 | 0.00% |